{"id":310163,"date":"2026-10-15T11:35:57","date_gmt":"2026-10-15T06:05:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=310163"},"modified":"2026-10-15T11:35:57","modified_gmt":"2026-10-15T06:05:57","slug":"diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/","title":{"rendered":"3 Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks With a Strong Future Roadmap: Suraksha Diagnostic, India Glycols and Redtape"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Suraksha Diagnostic Rs 318.30, P\/E 46.05. India Glycols Rs 349.85, P\/E 7.58. Redtape Rs 113.46, P\/E 25.49. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Diagnostic chain, renewable chemical and footwear brand stocks with the clearest long-term roadmaps today include Suraksha Diagnostic in diagnostic and pathology testing through a network of labs and collection centres, India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Redtape in footwear, apparel and accessories sold through its own brand stores and online channels. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 11.5% at India Glycols and 17.5% at Redtape. P\/E stands at 46.05 for Suraksha Diagnostic (industry 62.79), 7.58 for India Glycols (industry 54.53) and 25.49 for Redtape (industry 66.59). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Diagnostic chain, renewable chemical and footwear brand stocks give investors exposure to health testing, chemicals and branded footwear for everyday use. Volumes, store additions and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three diagnostic chain, renewable chemical and footwear brand stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Redtape for footwear, apparel and accessories sold through its own brand stores and online channels. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#What_Are_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\" title=\"What Are Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks?\">What Are Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_at_a_Glance\" title=\"Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks at a Glance\">Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Why_Do_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks Have a Strong Roadmap in India?\">Why Do Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\" title=\"Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline\">Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#India_Glycols_Green_Chemicals_and_Ethanol_Build_the_Next_Leg\" title=\"India Glycols: Green Chemicals and Ethanol Build the Next Leg\">India Glycols: Green Chemicals and Ethanol Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Redtape_A_Footwear_Brand_Anchors_the_Roadmap\" title=\"Redtape: A Footwear Brand Anchors the Roadmap\">Redtape: A Footwear Brand Anchors the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Best_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_in_India_Suraksha_Diagnostic_vs_India_Glycols_vs_Redtape_on_Key_Financials\" title=\"Best Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks in India: Suraksha Diagnostic vs India Glycols vs Redtape on Key Financials\">Best Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks in India: Suraksha Diagnostic vs India Glycols vs Redtape on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#How_to_Evaluate_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks to Buy Before You Invest\">How to Evaluate Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Risks_to_Consider_Before_Investing_in_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\" title=\"Risks to Consider Before Investing in Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks\">Risks to Consider Before Investing in Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#FAQs_on_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\" title=\"FAQs on Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks\">FAQs on Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Which_are_the_best_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best diagnostic chain, renewable chemical and footwear brand stocks in India with a strong roadmap?\">Which are the best diagnostic chain, renewable chemical and footwear brand stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\" title=\"Is Suraksha Diagnostic a good stock to buy now?\">Is Suraksha Diagnostic a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#What_is_the_PE_ratio_of_Suraksha_Diagnostic_India_Glycols_and_Redtape\" title=\"What is the P\/E ratio of Suraksha Diagnostic, India Glycols and Redtape?\">What is the P\/E ratio of Suraksha Diagnostic, India Glycols and Redtape?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Which_of_these_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_has_the_highest_return_on_equity\" title=\"Which of these diagnostic chain, renewable chemical and footwear brand stocks has the highest return on equity?\">Which of these diagnostic chain, renewable chemical and footwear brand stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#What_are_the_risks_of_investing_in_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks\" title=\"What are the risks of investing in diagnostic chain, renewable chemical and footwear brand stocks?\">What are the risks of investing in diagnostic chain, renewable chemical and footwear brand stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#How_did_Suraksha_Diagnostic_India_Glycols_and_Redtape_perform_in_Q1_FY27\" title=\"How did Suraksha Diagnostic, India Glycols and Redtape perform in Q1 FY27?\">How did Suraksha Diagnostic, India Glycols and Redtape perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#Do_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_pay_dividends\" title=\"Do diagnostic chain, renewable chemical and footwear brand stocks pay dividends?\">Do diagnostic chain, renewable chemical and footwear brand stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-roadmap-pathway-list\/#How_can_I_invest_in_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_in_India\" title=\"How can I invest in diagnostic chain, renewable chemical and footwear brand stocks in India?\">How can I invest in diagnostic chain, renewable chemical and footwear brand stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\"><\/span><strong>What Are Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnostic chain, renewable chemical and footwear brand stocks are shares of companies that run diagnostics, make chemicals or sell branded footwear. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_at_a_Glance\"><\/span><strong>Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three diagnostic chain, renewable chemical and footwear brand stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-ltd-share-price-today\">Suraksha Diagnostic<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">318.30<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,614<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/indiaglyco\/india-glycols-ltd-share-price-today\">India Glycols<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">349.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,397<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">54.53<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.58<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/redtape\/redtape-ltd-share-price-today\">Redtape<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">113.46<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,285<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.49<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">66.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.55%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.70<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare and consumer stocks, all three trade at a discount to their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnostic chain, renewable chemical and footwear brand stocks have a strong roadmap in India because rising health checks, ethanol blending and branded footwear demand keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Preventive health:<\/strong> More people test early and often.<\/li>\n<li><strong>Renewable chemicals:<\/strong> Ethanol and bio-based chemicals gain policy support.<\/li>\n<li><strong>Branded footwear:<\/strong> Shoppers shift towards organised brands.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\"><\/span><strong>Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Suraksha Diagnostic&#8217;s roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.<\/p>\n<p>Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.<\/p>\n<p>Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P\/E of 46.05 against an industry P\/E of 62.79, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"India_Glycols_Green_Chemicals_and_Ethanol_Build_the_Next_Leg\"><\/span><strong>India Glycols: Green Chemicals and Ethanol Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>India Glycols&#8217; roadmap rests on glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock, with ethanol blending and chemical demand supporting volumes.<\/p>\n<p>Revenue grew from Rs 2,889.84 crore in FY22 to Rs 4,216.34 crore in FY26, a 45.9% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 26.8% to Rs 292.76 crore. In Q1 FY27, revenue grew 19.3% to Rs 2,988.82 crore, and net profit rose 32.2% to Rs 96.83 crore. Operating margin was 7.12% in FY26.<\/p>\n<p>Debt to equity is 0.58 and return on equity is 9.98%. FY26 operating cash flow was Rs 769.16 crore against capital expenditure of Rs 823.48 crore. India Glycols paid a dividend of Rs 7.5 per share for FY26, a yield of 2.10%. At a P\/E of 7.58 against an industry P\/E of 54.53, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 7.58 against an industry P\/E of 54.53 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Redtape_A_Footwear_Brand_Anchors_the_Roadmap\"><\/span><strong>Redtape: A Footwear Brand Anchors the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Redtape&#8217;s roadmap rests on footwear, apparel and accessories sold through its own brand stores and online channels, with store expansion supporting growth.<\/p>\n<p>FY26 revenue was Rs 2,551.61 crore, 17.5% higher than FY25. FY26 net profit rose 41.5% to Rs 240.55 crore. In Q1 FY27, revenue grew 4.8% to Rs 496.42 crore, and net profit rose 15.2% to Rs 44.48 crore. Operating margin was 20.07% in FY26 and 20.50% in Q1 FY27 against 18.56% a year earlier.<\/p>\n<p>Debt to equity is 0.70 and return on equity is 23.55%. FY26 operating cash flow was Rs 174.01 crore against capital expenditure of Rs 85.92 crore. Redtape paid a dividend of Rs 2 per share for FY26, a yield of 1.76%. At a P\/E of 25.49 against an industry P\/E of 66.59, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 20.50% against 20.07% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_in_India_Suraksha_Diagnostic_vs_India_Glycols_vs_Redtape_on_Key_Financials\"><\/span><strong>Best Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks in India: Suraksha Diagnostic vs India Glycols vs Redtape on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best diagnostic chain, renewable chemical and footwear brand stocks in India, Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; India Glycols leads on the lowest P\/E and dividend yield; Redtape leads on FY26 net profit growth and return on equity. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Suraksha Diagnostic<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">India Glycols<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Redtape<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">313.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,216.34<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,551.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.40<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">292.76<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">240.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">41.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.01%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.12%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 net profit growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.49<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.53<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.10%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">81.83<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">769.16<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">174.01<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare and consumer earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen diagnostic chain, renewable chemical and footwear brand stocks and shortlist diagnostic chain, renewable chemical and footwear brand stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these diagnostic chain, renewable chemical and footwear brand stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\"><\/span><strong>Risks to Consider Before Investing in Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Suraksha Diagnostic, India Glycols and Redtape live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare and consumer stocks cover diagnostics, renewable chemicals and footwear. Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; India Glycols leads on the lowest P\/E and dividend yield; Redtape leads on FY26 net profit growth and return on equity.<\/p>\n<p>Across diagnostic chain, renewable chemical and footwear brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the diagnostic chain, renewable chemical and footwear brand stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Diagnostic_Chain_Renewable_Chemical_and_Footwear_Brand_Stocks\"><\/span><strong>FAQs on Diagnostic Chain, Renewable Chemical and Footwear Brand Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best diagnostic chain, renewable chemical and footwear brand stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic, India Glycols and Redtape stand out for their roadmaps in diagnostics, renewable chemicals and footwear. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 11.5% at India Glycols and 17.5% at Redtape, and return on equity ranges from 9.98% to 23.55%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\"><\/span><strong>Is Suraksha Diagnostic a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Suraksha_Diagnostic_India_Glycols_and_Redtape\"><\/span><strong>What is the P\/E ratio of Suraksha Diagnostic, India Glycols and Redtape?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 7.58 for India Glycols (industry 54.53) and 25.49 for Redtape (industry 66.59). All of them trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these diagnostic chain, renewable chemical and footwear brand stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Redtape has the highest return on equity at 23.55%, followed by Suraksha Diagnostic at 13.15% and India Glycols at 9.98%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks\"><\/span><strong>What are the risks of investing in diagnostic chain, renewable chemical and footwear brand stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Suraksha_Diagnostic_India_Glycols_and_Redtape_perform_in_Q1_FY27\"><\/span><strong>How did Suraksha Diagnostic, India Glycols and Redtape perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Redtape reported revenue of Rs 496.42 crore, up 4.8% year on year, and net profit rose 15.2% to Rs 44.48 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_pay_dividends\"><\/span><strong>Do diagnostic chain, renewable chemical and footwear brand stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 2.10% for India Glycols and 1.76% for Redtape, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_diagnostic_chain_renewable_chemical_and_footwear_brand_stocks_in_India\"><\/span><strong>How can I invest in diagnostic chain, renewable chemical and footwear brand stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy diagnostic chain, renewable chemical and footwear brand stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best diagnostic chain, renewable chemical and footwear brand stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic, India Glycols and Redtape stand out for their roadmaps in diagnostics, renewable chemicals and footwear. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 11.5% at India Glycols and 17.5% at Redtape, and return on equity ranges from 9.98% to 23.55%.\"}},{\"@type\":\"Question\",\"name\":\"Is Suraksha Diagnostic a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Suraksha Diagnostic, India Glycols and Redtape?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 7.58 for India Glycols (industry 54.53) and 25.49 for Redtape (industry 66.59). All of them trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these diagnostic chain, renewable chemical and footwear brand stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Redtape has the highest return on equity at 23.55%, followed by Suraksha Diagnostic at 13.15% and India Glycols at 9.98%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in diagnostic chain, renewable chemical and footwear brand stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.\"}},{\"@type\":\"Question\",\"name\":\"How did Suraksha Diagnostic, India Glycols and Redtape perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Redtape reported revenue of Rs 496.42 crore, up 4.8% year on year, and net profit rose 15.2% to Rs 44.48 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do diagnostic chain, renewable chemical and footwear brand stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 2.10% for India Glycols and 1.76% for Redtape, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in diagnostic chain, renewable chemical and footwear brand stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy diagnostic chain, renewable chemical and footwear brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Suraksha Diagnostic, India Glycols and Redtape compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":35,"featured_media":310162,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[12302,11010,11013,12328,12329,11131],"class_list":["post-310163","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-diagnostic-chain","tag-india-glycols","tag-redtape","tag-renewable-chemical-and-footwear-brand-stocks","tag-renewable-chemical-and-footwear-brand-stocks-to-buy","tag-suraksha-diagnostic"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["310162"],"rank_math_title":["Diagnostic Chain, Renewable Chemical and Footwear Stocks"],"rank_math_description":["Diagnostic chain, renewable chemical and footwear brand stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["diagnostic chain, renewable chemical and footwear brand stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-diagnostic-chain-renewable-chemical-and-footwear-brand-stocks-with-a-strong.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=310163"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310163\/revisions"}],"predecessor-version":[{"id":310164,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310163\/revisions\/310164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/310162"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=310163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=310163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=310163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}